BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents-5,421,0004,237,0002,385,000
Short Term Investments-1,391,0002,113,0001,885,000
Net Receivables-5,609,0004,916,0004,117,000
Inventory-1,166,0001,241,0001,221,000
Other Current Assets-691,000627,000366,000
Total Current Assets-14,854,00013,704,00010,415,000
Long Term Investments-2,765,0002,788,0004,766,000
Property Plant and Equipment-5,001,0004,980,0004,412,000
Goodwill-6,863,0006,875,0006,881,000
Intangible Assets-1,210,0001,385,0001,419,000
Accumulated Amortization----
Other Assets-2,858,0003,975,0003,855,000
Deferred Long Term Asset Charges-1,610,0002,996,0002,844,000
Total Assets-33,551,00033,707,00031,748,000
Current Liabilities
Accounts Payable-2,248,0001,664,0001,565,000
Short/Current Long Term Debt--749,000-
Other Current Liabilities-1,161,0001,707,0002,508,000
Total Current Liabilities-9,563,0008,841,0008,017,000
Long Term Debt-6,975,0005,716,0006,558,000
Other Liabilities-5,166,0002,803,0002,749,000
Deferred Long Term Liability Charges----
Minority Interest-106,000170,000158,000
Negative Goodwill----
Total Liabilities-21,704,00017,360,00017,324,000
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock-221,000221,000221,000
Retained Earnings-31,160,00033,513,00031,613,000
Treasury Stock--21,538,000-19,282,000-19,027,000
Capital Surplus-1,898,0001,725,0001,459,000
Other Stockholder Equity--2,289,000-2,503,000-2,468,000
Total Stockholder Equity13,640,00011,741,00016,177,00014,266,000
Net Tangible Assets5,847,0003,668,0007,917,0005,966,000